Addex Therapeutics Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2024 | 1 | -$1.28 | -$1.28 | -$1.28 |
| Q3 2024 | 1 | -$1.20 | -$1.20 | -$1.20 |
| Q4 2024 | 0 | -$1.21 | -$1.21 | -$1.21 |
| Q1 2025 | 0 | -$3.62 | -$3.62 | -$3.62 |
| Q2 2025 | 0 | -$1.21 | -$1.21 | -$1.21 |
| Q3 2025 | 0 | -$1.21 | -$1.21 | -$1.21 |
| Q4 2025 | 0 | -$1.21 | -$1.21 | -$1.21 |
Addex Therapeutics Ltd Earnings Date And Information
Addex Therapeutics Ltd last posted its earnings results on Monday, September 30th, 2024. The company reported $-1.77 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $1.7. The company had revenue of 115,277 for the quarter and had revenue of 1.61 M for the year. Addex Therapeutics Ltd has generated $0 earnings per share over the last year ($-0.14 diluted earnings per share) and currently has a price-to-earnings ratio of 182.94. Addex Therapeutics Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Addex Therapeutics Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2024 | Q2 2024 | $0.13 | $213,500 | $115,277 | ||
| 06/06/2024 | Q1 2024 | -$0.03 | $234,910 | |||
| 11/29/2023 | Q4 2023 | -$4.00 | -$0.03 | 3.97 | $153,451 | |
| 08/10/2023 | Q3 2023 | -$0.03 | $607,125 | $327,733 | ||
| 05/11/2023 | Q2 2023 | -$0.04 | $277,190 | $630,877 | ||
| 05/11/2023 | Q1 2023 | -$0.04 | $500,892 | |||
| 11/14/2022 | Q4 2022 | -$0.06 | $592,430 | |||
| 08/18/2022 | Q3 2022 | -$11.20 | -$0.09 | 11.11 | $228,632 | $409,417 |
| 05/05/2022 | Q2 2022 | -$10.40 | -$0.19 | 10.21 | $508,134 | $183,354 |
| 05/05/2022 | Q1 2022 | -$10.40 | -$0.15 | 10.25 | $237,237 | |
| 11/04/2021 | Q4 2021 | -$14.40 | -$0.13 | 14.27 | $397,488 | |
| 08/05/2021 | Q3 2021 | -$13.00 | -$0.11 | 12.89 | $414,321 | $682,002 |
| 05/05/2021 | Q2 2021 | -$13.00 | -$0.14 | 12.86 | $258,149 | $992,595 |
| 05/05/2021 | Q1 2021 | -$13.00 | -$0.08 | 12.92 | $844,223 | |
| 11/03/2020 | Q4 2020 | -$0.08 | $1.82 M | |||
| 11/03/2020 | Q3 2020 | -$0.12 | $27,264 | |||
| 06/29/2020 | Q2 2020 | -$0.12 | $860,793 | |||
| 03/30/2020 | Q1 2020 | -$0.16 | $904,060 | |||
| 04/24/2020 | Q4 2019 | -$0.14 | $1.04 M | |||
| 09/29/2019 | Q3 2019 | -$0.14 | $502,359 |
Addex Therapeutics Ltd Earnings: Frequently Asked Questions
-
When is Addex Therapeutics Ltd's earnings date?
Addex Therapeutics Ltd has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to Addex Therapeutics Ltd's earnings conference call?
The conference call for Addex Therapeutics Ltd's latest earnings report can be listened to online.
-
How can I read Addex Therapeutics Ltd's conference call transcript?
The conference call transcript for Addex Therapeutics Ltd's latest earnings report can be read online.
-
How much revenue does Addex Therapeutics Ltd generate each year?
Addex Therapeutics Ltd (:ADXN) has a recorded annual revenue of $1.61 M.
-
How much profit does Addex Therapeutics Ltd generate each year?
Addex Therapeutics Ltd (:ADXN) has a recorded net income of $1.61 M. Addex Therapeutics Ltd has generated $-0.14 earnings per share over the last four quarters.
-
What is Addex Therapeutics Ltd's price-to-earnings ratio?
Addex Therapeutics Ltd (:ADXN) has a price-to-earnings ratio of 182.94 and price/earnings-to-growth ratio is 2.63.
